Pioneering partnerships in cell and gene therapies for more than 30 years

Pioneering partnerships in cell and gene therapies for more than 30 years

In cell and gene therapy, from early clinical development to successful IND/CTA application, our customers around the world trust Miltenyi Bioindustry as their partner in rolling out new therapies. So can you. With our expertise, breakthrough platforms, and tailored service offerings, Miltenyi Bioindustry helps from early clinical trials to large-scale global operations.

The growth of our pioneering portfolio

Our commitment to making new therapies a reality began with the development of the CliniMACS® Plus Instrument, the world’s first automated cell separation device, and led to the FDA approval of the CliniMACS® CD34 Reagent System. The launch of the fully automated CliniMACS Prodigy® Platform set the standard for automated, scalable, and GMP-compliant cell processing and manufacturing. The latest addition of the associated CliniMACS® Electroporator and CliniMACS® Formulation Unit modules pushes this standard still further and opens up entirely new possibilities for true and fully integrated end-to-end solutions in cell and gene therapy manufacturing. With this, Miltenyi Bioindustry is able to offer an all-inclusive platform and service package to add true value to your therapy products.

With an emphasis on immunotherapy, regenerative medicine, and graft engineering, Miltenyi Biotec is at the forefront of pioneering clinical research in cell and gene therapy. Our acquisition and integration of the lentiviral vector manufacturing business from Lentigen, and Living Pharma’s CAR T cell therapy technology, has strengthened this still further, allowing us to offer lentiviral vector and cell manufacturing services on a larger scale.  

We develop, optimize, and engineer robust, GMP-compliant cell manufacturing processes that are specifically tailored to our customers’ cell therapy needs. With our CliniMACS Cell Factory® Facilities, now available on three continents, we provide standardized and consistent processes tailored to regional requirements and challenges. We are known for our unparalleled commitment to innovation and technical excellence, drawing on our own time-tested technologies and resources.

Proven competency in GMP settings

Around the globe, Miltenyi Biotec products and know-how are in use in trailblazing labs, clinics, and manufacturing sites. Our technologies help to realize more than 100,000 cell therapy procedures, hundreds of clinical trials, and treatments for over 6,000 patients annually. Having passed numerous audits, all our customers trust Miltenyi Biotec to deliver consistently high-quality products with a solid regulatory track record. Working with us means tailored consulting and innovative technologies as the foundation of our full-service CDMO offerings.

From concept to commercialization: We're there to support you

As our successful clients can confirm, we are a strong partner with the mission to quickly move you through development and scale-up challenges, right through to successful IND/CTA and towards BLA/MAA submission. We can back up that claim with decades of experience in lentiviral vector design, process development, and GMP-compliant manufacturing, as well as in cell processing and clinical cell therapy manufacturing. With Miltenyi Bioindustry, these capabilities are leveraged by a highly skilled and motivated team of process and analytical experts to provide customized and commercially viable solutions. Reach out to us and let your cell and gene therapy vision become reality. 

Let's talk about how we can help you

Contact us